keyword
MENU ▼
Read by QxMD icon Read
search

DR TB

keyword
https://www.readbyqxmd.com/read/28709496/drug-resistant-tuberculosis-coexisting-with-invasive-candidiasis-in-an-immunocompetent-30-year-old-woman-a-case-report
#1
Rakhee Khanduri, Sushant Khanduri, Sanjeev Kumar, Ankur Saini, Arti Kotwal
Invasive candidiasis coexisting with drug-resistant Mycobacterium tuberculosis (DR-TB) in the immunocompetent patient is a rare entity. We report a 30-year-old woman, nondiabetic, who presented to us with complaints of acute onset cough, breathlessness, and fever since 20 days. On thorough investigations, she was diagnosed to be suffering from coexisting drug-resistant tuberculosis and invasive candidiasis. Prompt treatment initiated at right time helped us in saving her life. The unique presentation of this case and that too in an immunocompetent female makes it an interesting case...
July 2017: Indian Journal of Tuberculosis
https://www.readbyqxmd.com/read/28623123/screening-mutations-in-drug-resistant-mycobacterium-tuberculosis-strains-in-yunnan-china
#2
Daoqun Li, Yuzhu Song, Cheng-Lin Zhang, Xiaofei Li, Xueshan Xia, A-Mei Zhang
Drug-resistant tuberculosis (DR-TB), especially multidrug-resistant tuberculosis (MDR-TB), is a serious medical and societal problem in China. The purpose of this study was to evaluate the mutation characteristics of drug-resistant Mycobacterium tuberculosis (M. tuberculosis) isolates in Yunnan, China. Drug susceptibility testing (DST) was performed in 523 clinical M. tuberculosis isolates. Six drug resistance genes (katG, inhA, rpoB, rpsL, embB, and pncA) were selected to screen for mutations. In total, 54 clinical M...
June 13, 2017: Journal of Infection and Public Health
https://www.readbyqxmd.com/read/28619539/systemic-immunological-changes-in-patients-with-distinct-clinical-outcomes-during-mycobacterium-tuberculosis-infection
#3
Tatiane Figueiredo Morais-Papini, Jordana Grazziela Alves Coelho-Dos-Reis, Ana Paula Barbosa Wendling, Lis Ribeiro do Vale Antonelli, Pryscilla Fanini Wowk, Vânia Luiza Deperon Bonato, Valéria Maria Augusto, Silvana Elói-Santos, Olindo Assis Martins-Filho, Cláudia Martins Carneiro, Andréa Teixeira-Carvalho
BACKGROUND: The lung lesions in an individual infected with tuberculosis (TB) are surprisingly variable and independent of each other. However, there is no circulating biomarker yet able to segregate patients according to the extent of lung lesions. MATERIALS AND METHODS: In this study, the phenotypic and functional profile of leukocytes of patients with active pulmonary tuberculosis (TB) and controls (CO) were fully scrutinized by immunophenotyping assays and in vitro short-term whole blood culture...
May 26, 2017: Immunobiology
https://www.readbyqxmd.com/read/28604316/when-students-become-patients-tb-disease-among-medical-undergraduates-in-cape-town-south-africa
#4
Helene-Mari Van der Westhuizen, Angela Dramowski
BACKGROUND: Medical students acquire latent tuberculosis (TB) infection at a rate of 23 cases/100 person-years. The frequency and impact of occupational TB disease in this population are unknown. METHODS: A self-administered questionnaire was distributed via email and social media to current medical students and recently graduated doctors (2010 - 2015) at two medical schools in Cape Town. Individuals who had developed TB disease as undergraduate students were eligible to participate...
May 24, 2017: South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde
https://www.readbyqxmd.com/read/28578621/drug-resistant-tuberculosis-in-zhejiang-province-china-an-updated-analysis-of-time-trends-1999-2013
#5
Beibei Wu, Le Zhang, Zhengwei Liu, Haibo He, Aizhen Pan, Fei Wang, Mingwu Zhang, Bin Chen, Zuhong Lu, Songhua Chen, Xiaomeng Wang
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) hinder the progress of TB control. OBJECTIVE: To track the trend of drug-resistant tuberculosis (DR-TB) prevalence in Zhejiang Province from 1999 to 2013, and identify risk factors of resistance to second-line drugs among MDR-TB patients. DESIGN: Four DR-TB surveys had been done in Zhejiang Province in 1999, 2004, 2008 and 2013 through questionnaires, in which demographic and epidemiological items were included...
2017: Global Health Action
https://www.readbyqxmd.com/read/28562103/the-paradigm-shift-to-end-tuberculosis-are-we-ready-to-assume-the-changes
#6
Ignacio Monedero, Rajita Bhavaraju, Alberto Mendoza-Ticona, Adrián Sánchez-Montalvá
Tuberculosis (TB) is the number one infectious disease killer and exemplifies the most neglected of them. Drug-susceptible TB presents with high mortality especially in atypical forms, disproportionally affecting immunosuppressed and vulnerable populations. The drug-resistant TB (DR-TB) epidemic, a world crisis, is sustained and increased through person-to-person transmission in households and the community. TB diagnostics and treatment in recent years are highly evolving fields. New rapid molecular tests are changing the perspectives in diagnosis and resistance screening...
June 5, 2017: Expert Review of Respiratory Medicine
https://www.readbyqxmd.com/read/28494250/recent-developments-of-coumarin-containing-derivatives-and-their-anti-tubercular-activity
#7
Yuan-Qiang Hu, Zhi Xu, Shu Zhang, Xiang Wu, Jun-Wei Ding, Zao-Sheng Lv, Lian-Shun Feng
Tuberculosis (TB) is a lift-threatening chronic deadliest infectious disease caused predominantly by Mycobacterium tuberculosis (MTB) which affects primarily the lungs (pulmonary TB) apart from other vital organs. The emergence of drug-resistant TB (DR-TB), multidrug-resistant TB (MDR-TB), extensively drug-resistant TB (XDR-TB) and the recently cases of totally drug resistant (TDR) towards currently accessible standard drugs was increased up to alarming level in the recent decades. In pursuit of searching new anti-TB agents, numerous of derivatives have been synthesized and screened for their anti-TB activity...
May 2, 2017: European Journal of Medicinal Chemistry
https://www.readbyqxmd.com/read/28480653/the-rate-of-drug-resistant-tuberculosis-in-korean-children-and-adolescents-since-2007
#8
Hyun Jung Kim, Hyung Ho Yoon, Byung Wook Eun, Youngmin Ahn, Sungweon Ryoo, Hee Jin Kim
The incidence of drug-resistant tuberculosis (DR-TB) in pediatric populations is a critical indicator of national TB management and treatment strategies. Limited data exist regarding the rate of pediatric DR-TB. In this study, we aimed to analyze the status of DR-TB in Korean children from 2007 to 2013. We analyzed specimens submitted to the Korean Institute of Tuberculosis using Mycobacterium tuberculosis culture and drug susceptibility tests (DSTs) from January 2007 through December 2013. Specimens from patients ≤ 19 years of age were included...
June 2017: Journal of Korean Medical Science
https://www.readbyqxmd.com/read/28419314/adverse-drug-reactions-during-drug-resistant-tb-treatment-in-high-hiv-prevalence-settings-a-systematic-review-and-meta-analysis
#9
Kathryn Schnippel, Cynthia Firnhaber, Rebecca Berhanu, Liesl Page-Shipp, Edina Sinanovic
Objectives: To estimate the prevalence of adverse drug reactions or events (ADR) during drug-resistant TB (DR-TB) treatment in the context of settings with high HIV prevalence (at least 20% of patients). Methods: We conducted a systematic review and meta-analysis of articles in PubMed and Scopus. Pooled proportions of patients experiencing adverse events and relative risk with 95% CI were calculated. Results: The search yielded 24 studies, all observational cohorts...
April 16, 2017: Journal of Antimicrobial Chemotherapy
https://www.readbyqxmd.com/read/28399971/drug-resistant-tuberculosis-in-patients-with-minimal-symptoms-favourable-outcomes-in-the-absence-of-treatment
#10
M Loveday, A Ramjee, G Osburn, I Master, G Kabera, J C M Brust, N Padayatchi, R Warren, G Theron
SETTING: Referral hospital for drug-resistant tuberculosis (DR-TB) in KwaZulu-Natal Province, South Africa. OBJECTIVE: To review the clinical outcomes of patients (age  14 years) with a laboratory-confirmed diagnosis of DR-TB who had minimal symptoms and/or did not have chest radiographic evidence of active disease at referral. These patients were not started on treatment, but were enrolled in an observation programme with follow-up at 2, 6 and 12 months. RESULTS: Of 3345 referred patients diagnosed with DR-TB, 192 (6%) were enrolled in the observation programme...
May 1, 2017: International Journal of Tuberculosis and Lung Disease
https://www.readbyqxmd.com/read/28395347/burden-of-occupationally-acquired-pulmonary-tuberculosis-among-healthcare-workers-in-the-usa-a-risk-analysis
#11
Rachael M Jones
Pulmonary tuberculosis (TB) infection remains an occupational health burden among healthcare workers (HCWs), but current surveillance data do not allow for attribution of pulmonary TB disease to occupational or community exposures. The objectives of this study were to estimate the annual number of occupationally acquired pulmonary TB infections among HCW in acute care settings (ambulatory care, emergency departments (EDs), and hospitals) in the USA, and to estimate the impact of increased compliance with respiratory protection...
March 1, 2017: Annals of Work Exposures and Health
https://www.readbyqxmd.com/read/28390957/isoniazid-derivatives-and-their-anti-tubercular-activity
#12
REVIEW
Yuan-Qiang Hu, Shu Zhang, Feng Zhao, Chuan Gao, Lian-Shun Feng, Zao-Sheng Lv, Zhi Xu, Xiang Wu
Tuberculosis (TB), which has been a scourge of humanity for thousands of years, is a worldwide pandemic disease caused mainly by Mycobacterium tuberculosis (MTB). The emergence of drug-resistant TB (DR-TB), multidrug-resistant TB (MDR-TB), extensively drug-resistant TB (XDR-TB) and totally drug-resistant TB (TDR-TB) increase the challenges to eliminate TB worldwide. Isoniazid (INH), a critical frontline anti-TB drug, is one of the most effective drugs used to treatment of TB infection for more than 60 years...
April 3, 2017: European Journal of Medicinal Chemistry
https://www.readbyqxmd.com/read/28386407/current-tools-available-for-the-diagnosis-of-drug-resistant-tuberculosis
#13
REVIEW
Christopher Gilpin, A Korobitsyn, K Weyer
Drug-resistant tuberculosis (DR-TB) poses a major threat to control of tuberculosis worldwide. Diagnosis and treatment of DR-TB are considerably more difficult than for drug-susceptible tuberculosis (TB) and require higher level infrastructure and proficiency from laboratory specialists and clinicians. The World Health Organization (WHO) End TB Strategy calls for early diagnosis and initiation of appropriate treatment of all persons of all ages with any form of drug-susceptible TB or DR-TB. This requires ensuring access to WHO-recommended rapid diagnostics and universal drug susceptibility testing (DST) for all persons with signs and symptoms of TB...
December 2016: Therapeutic Advances in Infectious Disease
https://www.readbyqxmd.com/read/28360464/assess-drug-resistance-pattern-and-genetic-profile-of-mycobacterium-tuberculosis-clinical-isolates-by-molecular-typing-methods-using-direct-repeats-and-is6110-in-pulmonary-tuberculosis-cases
#14
Deepika Kalo, Surya Kant, Kanchan Srivastava, Ajay K Sharma
BACKGROUND: Tuberculosis (TB), a highly contagious disease that sees no gender, age, or race is mainly a disease of lungs. According to World Health Organization, a TB patient can be completely cured with 6-9 months of anti-TB treatment under directly observed treatment short course. OBJECTIVES: The aim of this study was to check the mono, multi- and triple-drug resistance to first line drugs (FLDs) among TB patients and to access their genetic profile using DR 3074, DR 0270, DR 0642, DR 2068, and DR 4110 using molecular techniques...
March 2017: Lung India: Official Organ of Indian Chest Society
https://www.readbyqxmd.com/read/28319425/overcoming-challenges-in-the-diagnosis-prevention-and-treatment-of-pediatric-drug-resistant-tuberculosis
#15
Sylvie Jonckheree, Jennifer Furin
Drug-resistant tuberculosis (DR-TB) is a growing global health threat and children are especially vulnerable to becoming infected and sick with DR-TB. There is a growing body of evidence on the optimal diagnosis, treatment and prevention of DR-TB in this vulnerable population. Areas covered: A comprehensive review of the literature on DR-TB in children was done using PubMed and Ovid databases up to 31 December 2016. Topic areas covered included diagnosis of DR-TB, treatment of DR-TB - including novel medications and regimens, prevention of DR-TB, community-based care, and stigma/discrimination...
May 2017: Expert Review of Respiratory Medicine
https://www.readbyqxmd.com/read/28317805/prevalence-and-genetic-determinant-of-drug-resistant-tuberculosis-among-patients-completing-intensive-phase-of-treatment-in-a-tertiary-referral-center-in-nigeria
#16
Aminu Bashir Mohammad, Garba Iliyasu, Abdulrazaq Garba Habib
BACKGROUND: Drug-resistant tuberculosis (DR-TB) continues to be a challenge in developing countries with poor resources. Despite the high prevalence of primary DR-TB, its routine screening prior to the treatment is not performed in public hospitals in Nigeria. Data regarding drug resistance and its genetic determinant among follow-up patients with TB are lacking in Nigeria. Hence, the aim of this study was to determine the prevalence and genetic determinant of drug resistance among the follow-up patients with TB in a tertiary hospital in Nigeria...
January 2017: International Journal of Mycobacteriology
https://www.readbyqxmd.com/read/28317798/nontuberculous-mycobacterial-species-and-mycobacterium-tuberculosis-complex-coinfection-in-patients-with-pulmonary-tuberculosis-in-dr-soetomo-hospital-surabaya-indonesia
#17
Ni Made Mertaniasih, Deby Kusumaningrum, Eko Budi Koendhori, Tutik Kusmiati, Desak Nyoman Surya Suameitria Dewi
OBJECTIVE/BACKGROUND: The aim of this study was to analyze the detection of nontuberculous mycobacterial (NTM) species derived from sputum specimens of pulmonary tuberculosis (TB) suspects. Increasing prevalence and incidence of pulmonary infection by NTM species have widely been reported in several countries with geographical variation. MATERIALS AND METHODS: Between January 2014 and September 2015, sputum specimens from chronic pulmonary TB suspect patients were analyzed...
January 2017: International Journal of Mycobacteriology
https://www.readbyqxmd.com/read/28285302/need-for-revision-of-guidelines-for-management-of-dr-tb-in-children
#18
Manju Kumari, Ira Shah
No abstract text is available yet for this article.
February 15, 2017: Indian Pediatrics
https://www.readbyqxmd.com/read/28237037/the-effect-size-of-type-2-diabetes-mellitus-on-tuberculosis-drug-resistance-and-adverse-treatment-outcomes
#19
Lucia Monserrat Perez-Navarro, Blanca I Restrepo, Francisco Javier Fuentes-Dominguez, Ravindranath Duggirala, Jaime Morales-Romero, Juan Carlos López-Alvarenga, Iñaki Comas, Roberto Zenteno-Cuevas
OBJECTIVE: To evaluate the effect size of type 2 diabetes mellitus (T2DM) on tuberculosis (TB) treatment outcomes and multi drug resistance (MDR). METHODS: A cohort with 507 individuals with diagnosed TB included 183 with coexistence of T2DM and TB (TB-T2DM). Participants were identified at the time of TB diagnosis and followed during the course of TB treatment. Then we computed relative risks and adjustments by Cox proportional hazards for outcome variables (drug resistance, death, relapse, treatment failure), and the size of their effect as Cohen's-d...
March 2017: Tuberculosis
https://www.readbyqxmd.com/read/28164036/primary-extrapulmonary-multidrug-resistant-tuberculosis-in-an-immunocompetent-child-presenting-with-pleural-effusion
#20
Sankalp Yadav, Gautam Rawal
The developing countries are having a number of public health issues. The situation in these resource-limited countries is scary due to the huge burden of infectious diseases like tuberculosis (TB). The latest reports from the WHO shows a high number of drug resistant cases even in the pediatric age groups. Also, the lack of suspicion of drug resistant TB (DR-TB) in the pediatric cases, especially in the absence of a past or family history may lead to delay in diagnosis and flaring-up of the disease. We herein present the very first case of the primary multidrug-resistant TB in an HIV negative child who presented with the left sided pleural effusion...
January 2017: Translational pediatrics
keyword
keyword
84412
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"